Valmark Advisers’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.46M Buy
187,444
+926
+0.5% +$22.1K 0.05% 165
2026
Q1
$4.45M Sell
186,518
-2,255
-1% -$54.3K 0.05% 150
2025
Q4
$4.57M Sell
188,773
-9,155
-5% -$221K 0.06% 139
2025
Q3
$4.78M Buy
197,928
+64,759
+49% +$1.56M 0.06% 129
2025
Q2
$3.2M Sell
133,169
-13,556
-9% -$321K 0.04% 158
2025
Q1
$3.48M Buy
146,725
+15,229
+12% +$360K 0.05% 140
2024
Q4
$3.08M Buy
131,496
+122,980
+1,444% +$2.92M 0.05% 150
2024
Q3
$205K Sell
8,516
-66,657
-89% -$1.59M ﹤0.01% 577
2024
Q2
$1.75M Sell
75,173
-15,351
-17% -$358K 0.03% 197
2024
Q1
$2.13M Buy
+90,524
New +$2.13M 0.04% 165

Other funds holding IBD

Valmark Advisers's IBD Position: Q2 2026 in Review

Valmark Advisers increased its Inspire Corporate Bond ETF (IBD) stake by 0.5% in Q2 2026, buying an estimated $22.1K and bringing the position to 187,444 shares worth $4.46M. The position accounts for 0.05% of the portfolio, ranked #165.

Valmark Advisers first reported a position in IBD in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.78M in Q3 2025. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Valmark Advisers held 187,444 shares of Inspire Corporate Bond ETF worth $4.46M as of Q2 2026.
  • Valmark Advisers bought 926 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $22.1K.
  • Inspire Corporate Bond ETF made up 0.05% of Valmark Advisers's portfolio in Q2 2026, its #165 holding.
  • Valmark Advisers first reported a position in Inspire Corporate Bond ETF in Q1 2024 and has held it in 10 quarters since.
  • Valmark Advisers's Inspire Corporate Bond ETF position peaked at $4.78M in Q3 2025.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Valmark Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.